- Home
- DYNX vs LXEO Comparison
DYNX vs LXEO Comparison
Compare DYNX & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYNX
- LXEO
- Stock Information
- Founded
- DYNX 2024
- LXEO 2017
- Country
- DYNX United States
- LXEO United States
- Employees
- DYNX N/A
- LXEO 72
- Industry
- DYNX
- LXEO
- Sector
- DYNX
- LXEO
- Exchange
- DYNX NYSE
- LXEO Nasdaq
- Market Cap
- DYNX 219.9M
- LXEO 190.9M
- IPO Year
- DYNX 2024
- LXEO 2023
- Fundamental
- Price
- DYNX $9.83
- LXEO $5.66
- Analyst Decision
- DYNX
- LXEO Strong Buy
- Analyst Count
- DYNX 0
- LXEO 5
- Target Price
- DYNX N/A
- LXEO $23.80
- AVG Volume (30 Days)
- DYNX 10.3K
- LXEO 219.1K
- Earning Date
- DYNX 01-01-0001
- LXEO 02-11-2025
- Dividend Yield
- DYNX N/A
- LXEO N/A
- EPS Growth
- DYNX N/A
- LXEO N/A
- EPS
- DYNX N/A
- LXEO N/A
- Revenue
- DYNX $2,124,981.00
- LXEO N/A
- Revenue This Year
- DYNX N/A
- LXEO N/A
- Revenue Next Year
- DYNX N/A
- LXEO N/A
- P/E Ratio
- DYNX N/A
- LXEO N/A
- Revenue Growth
- DYNX N/A
- LXEO N/A
- 52 Week Low
- DYNX $9.91
- LXEO $4.67
- 52 Week High
- DYNX $9.99
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- DYNX N/A
- LXEO 43.99
- Support Level
- DYNX N/A
- LXEO $5.18
- Resistance Level
- DYNX N/A
- LXEO $5.60
- Average True Range (ATR)
- DYNX 0.00
- LXEO 0.54
- MACD
- DYNX 0.00
- LXEO 0.04
- Stochastic Oscillator
- DYNX 0.00
- LXEO 51.01
About DYNX DYNAMIX CORP
Dynamix Corp is a blank check company.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.